Addressing the Challenges of Systematic Reviews
Systematic reviews are the gold standard for evidence synthesis in healthcare, forming the foundation of clinical guidelines, regulatory decisions, and health technology assessments. However, the traditional manual process is incredibly time-consuming and resource-intensive, often taking 8–24 months to complete and costing upwards of $100,000 per review.
The exponential growth of medical literature compounds this challenge. With over 2 million new biomedical publications added annually, comprehensive literature searches now routinely yield tens of thousands of citations. Manual screening at this scale is simply inefficient — it is becoming practically impossible for research teams to manage while maintaining quality and timeliness.
The Burden of Title and Abstract Screening
Title and abstract (TiAb) screening represents the most time-consuming phase of systematic reviews, often accounting for 40–60% of the total project timeline. Reviewers must evaluate thousands of citations against complex inclusion and exclusion criteria, a process that requires sustained concentration and expertise.
Manual screening is also inherently prone to human error and inconsistency. Studies show inter-reviewer agreement rates typically range from 70–85%, meaning different reviewers frequently disagree on whether studies should be included. Reviewer fatigue, cognitive biases, and varying interpretations of inclusion criteria all contribute to these inconsistencies, potentially compromising the quality and reproducibility of systematic reviews.
"The traditional approach to systematic reviews is unsustainable. We need innovative solutions that maintain scientific rigour while dramatically improving efficiency."
— Dr. Ghayath Janoudi, CEO, Loon
Introducing Loon Lens™
Loon Lens™ represents a breakthrough in AI-powered literature screening. Unlike traditional tools that require extensive training data or manual calibration, Loon Lens™ operates autonomously from day one. Simply provide your inclusion and exclusion criteria, and the system handles the rest — no coding, no complex setup, no lengthy training periods.
- No pre-training required: screening starts from your eligibility criteria alone
- Calibrated confidence scores: every decision carries a confidence score, routing no more than ~5% of outputs to expert validation
- Explainable, HTA-grade: full audit trails and transparent reasoning for every screening decision
- Scientific validation: peer-reviewed performance across therapeutic areas and study designs
- Scalable performance: tens of thousands of citations without added reviewers
The Validation Study: Rigorous Testing Across Disciplines
The validation study included systematic reviews from oncology, cardiology, infectious diseases, neurology, and rare diseases. This diversity ensured that Loon Lens™ was tested across varying levels of complexity, terminology, and study designs. Each review had been completed using traditional manual methods, providing gold-standard comparisons.
- 8 systematic reviews analysed
- 3,796 total citations screened
- 5 therapeutic areas covered
- Gold standard: expert human screening
Results: Exceptional Performance Across All Metrics
The validation study demonstrated Loon Lens™'s exceptional performance across all key metrics:
- Sensitivity (recall): 99.0%
- Accuracy: 99.0%
- Specificity: 99.1%
- Precision: 89.9% (with ~5% confidence-routed validation)
- Negative predictive value: 99.9%
Beyond accuracy, Loon Lens™ delivers transformative efficiency gains. Reviews that traditionally require 8–24 months are completed in 2–4 weeks. This is how traditional and Loon AI® costs and timelines compare for a systematic literature review prepared for an HTA submission:
Traditional approach
- Timeline: 9 months
- Cost: $170,000–$240,000
- Team: 6 reviewers
- Studies screened: 28,000
Loon Lens™ approach
- Timeline: 3–4 weeks
- Cost savings: up to 95%
- Team: 1 reviewer (validation)
"Loon Lens™ transforms systematic reviews from a burden into a competitive advantage. What used to take teams months or years now takes days or weeks, with better consistency and documentation."
— Dr. Ghayath Janoudi, CEO, Loon
Technical Innovations Behind Loon Lens™
Each Loon Lens™ agent is powered by state-of-the-art foundational models built on the transformer architecture, specifically focused and orchestrated for biomedical literature. Unlike generic AI chatbots, these agentic systems specialise in — and are validated to perform — evidence synthesis tasks across multiple clinical domains and study designs. This domain-specific focus enables highly accurate interpretation of methods sections, results tables, and supplementary materials.
Loon Lens™ accurately identifies when outputs carry a degree of uncertainty that may require human intervention. This significantly de-risks the implementation of AI systems in high-stakes environments and allows for a much more streamlined expert-in-the-loop validation: with confidence-based validation, an expert needs to validate no more than 5% of the AI output.
Every screening decision made by Loon Lens™ is processed by our proprietary architecture featuring an orchestrated array of 300+ specialised AI agents, each designed for a distinct task. Unlike monolithic LLMs, this modular, patent-pending Neurosymbolic Ensemble AI System achieves superior accuracy, explainability, and calibration across complex clinical domains, disease areas, and study methodologies.
"The explainability of Loon Lens™ is crucial in an HTA submission. Loon Lens™ demonstrates to HTA bodies and regulators exactly how decisions were made, with full audit trails. This transparency strengthens every submission."
— Dr. Ghayath Janoudi, CEO, Loon
Seamless Implementation and Integration
Loon Lens™ is designed to enhance, not replace, your existing systematic review workflow. The platform works seamlessly with exports from popular reference management tools like Zotero and EndNote — you can continue using your preferred reference management and review coordination tools while leveraging Loon Lens™ for accelerated screening and data extraction.
We offer multiple deployment models to meet different organisational needs, and most teams are productive with Loon Lens™ within days. Our onboarding process includes personalised training for your specific use cases, and ongoing support. The intuitive interface means reviewers can focus on their expertise rather than learning complex software.
The Future of Evidence Synthesis
Loon Lens™ enables true living systematic reviews that automatically update as new evidence emerges. Our agents continuously monitor publication databases, preprint servers, and clinical trial registries. When relevant new studies appear, they are automatically screened and flagged for inclusion, keeping your evidence base current without manual effort.
We are continuously expanding Loon Lens™ capabilities based on user needs and technological advances. Upcoming features include:
- Network meta-analysis automation
- Real-world evidence integration
- Multi-language screening capabilities
- Automated GRADE assessment
- Direct HTA dossier generation